DFIB Cardiac Science (MM)

Cardiac Science Announces Agreement to Dismiss Class Action Lawsuit Related to Proposed Merger IRVINE, Calif., June 27 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic public-access defibrillators today announced that it has executed a memorandum of understanding with plaintiffs' class counsel to dismiss the class action lawsuit pending in the Delaware Chancery Court. The lawsuits related to Cardiac Science's proposed merger with Quinton Cardiology Systems, Inc. (NASDAQ:QUIN). Plaintiffs' class counsel has agreed to withdraw their motion for preliminary injunction and release all parties associated with the transaction regarding disclosure claims involving the merger. Counsel for an institutional shareholder in a related case has also entered into the same agreement. In addition, plaintiffs' class counsel in the Delaware class action has agreed to dismiss all remaining damage claims without prejudice. In exchange for such agreements, Cardiac Science agreed to make additional disclosures in its registration statement on Form S-4 filed with the Securities and Exchange Commission in connection with the proposed merger transaction. A final settlement agreement is subject to approval by the Delaware Chancery Court. About Cardiac Science Cardiac Science develops, manufactures and markets a complete line of Powerheart(R) brand, automated public access defibrillators (AEDs), and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The company makes the Powerheart(R) CRM(R), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information please visit http://www.cardiacscience.com/ or call (949) 797-3800. Contact: Rene Caron (Investors) Roderick de Greef Len Hall (Media) EVP and CFO Allen & Caron Inc. Cardiac Science,Inc. (949) 474-4300 (949) 797-3800 DATASOURCE: Cardiac Science, Inc. CONTACT: Investors, Rene Caron, , or Media, Len Hall, , both of Allen & Caron Inc., +1-949-474-4300, for Cardiac Science, Inc.; or Roderick de Greef, EVP and CFO of Cardiac Science,Inc., +1-949-797-3800 Web site: http://www.cardiacscience.com/

Copyright